Delivered dose to scrotum in rectal cancer radiotherapy by thermoluminescence dosimetry comparing to dose calculated by planning software

Background: Colorectal carcinoma is a common malignancy, in treatment of which pelvic radiotherapy plays an important role. But this may lead to azospermia. We designed a study to determine the delivered dose to the testis with thermoluminescence dosimetry (TLD) and compare it to the dose calculated...

Full description

Bibliographic Details
Main Authors: Peiman Haddad, Zhaleh Karimimoghaddam, Farshid Farhan, Mahbod Esfahani, Mahdieh Afkhami, Farnaz Amouzegar-Hashemi
Format: Article
Language:fas
Published: Tehran University of Medical Sciences 2014-02-01
Series:Tehran University Medical Journal
Subjects:
Online Access:http://tumj.tums.ac.ir/browse.php?a_code=A-10-25-5164&slc_lang=en&sid=1
_version_ 1818475448974180352
author Peiman Haddad
Zhaleh Karimimoghaddam
Farshid Farhan
Mahbod Esfahani
Mahdieh Afkhami
Farnaz Amouzegar-Hashemi
author_facet Peiman Haddad
Zhaleh Karimimoghaddam
Farshid Farhan
Mahbod Esfahani
Mahdieh Afkhami
Farnaz Amouzegar-Hashemi
author_sort Peiman Haddad
collection DOAJ
description Background: Colorectal carcinoma is a common malignancy, in treatment of which pelvic radiotherapy plays an important role. But this may lead to azospermia. We designed a study to determine the delivered dose to the testis with thermoluminescence dosimetry (TLD) and compare it to the dose calculated by the Three-dimensional planning software. Methods: We measured the testicular doses by TLD; the TLDs were fixed to the scrotum in six points anteriorly and posteriorly in two random fractions of the radiation course. All patients received a 50-50.4 Gy radiation dose to the pelvis in a prone position with standard fractionation and 3-dimensional planning, through three or four fields. The average dose of the TLD measurements was compared to the average of 6 relevant point doses calculated by the planning software. Results: In 33 patients with a mean age of 56 years, the mean testis dose of radiation measured by TLD was 3.77 Gy, equal to 7.5% of the total prescribed dose. The mean of point doses calculated by the 3-dimensional planning software was 4.11 Gy, equal to 8.1% of the total prescribed dose. A significant relationship was seen between the position of the inferior edge of the fields and the mean testis dose (P= 0.04). Also body mass index (BMI) was inversely related with the testicular dose (P= 0.049). Conclusion: In this study, the mean testis dose of radiation was 3.77 Gy, similar to the dose calculated by the planning software (4.11 Gy). This dose could be significantly harmful for spermatogenesis, though low doses of scattered radiation to the testis in fractionated radiotherapy might be followed with better recovery. Based on above findings, careful attention to testicular dose in radiotherapy of rectal cancer for the males desiring continued fertility seems to be required.
first_indexed 2024-12-10T09:12:43Z
format Article
id doaj.art-88de92c80a0f46a4943699bf65c264ac
institution Directory Open Access Journal
issn 1683-1764
1735-7322
language fas
last_indexed 2024-12-10T09:12:43Z
publishDate 2014-02-01
publisher Tehran University of Medical Sciences
record_format Article
series Tehran University Medical Journal
spelling doaj.art-88de92c80a0f46a4943699bf65c264ac2022-12-22T01:54:58ZfasTehran University of Medical SciencesTehran University Medical Journal1683-17641735-73222014-02-017111707712Delivered dose to scrotum in rectal cancer radiotherapy by thermoluminescence dosimetry comparing to dose calculated by planning softwarePeiman Haddad 0Zhaleh Karimimoghaddam 1Farshid Farhan 2Mahbod Esfahani 3Mahdieh Afkhami 4Farnaz Amouzegar-Hashemi5 Department of Radiation Oncology, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran. Department of Radiation Oncology, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran. Department of Radiation Oncology, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran. Department of Radiation Physics, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran. Department of Radiation Physics, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran. Department of Radiation Oncology, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran. Background: Colorectal carcinoma is a common malignancy, in treatment of which pelvic radiotherapy plays an important role. But this may lead to azospermia. We designed a study to determine the delivered dose to the testis with thermoluminescence dosimetry (TLD) and compare it to the dose calculated by the Three-dimensional planning software. Methods: We measured the testicular doses by TLD; the TLDs were fixed to the scrotum in six points anteriorly and posteriorly in two random fractions of the radiation course. All patients received a 50-50.4 Gy radiation dose to the pelvis in a prone position with standard fractionation and 3-dimensional planning, through three or four fields. The average dose of the TLD measurements was compared to the average of 6 relevant point doses calculated by the planning software. Results: In 33 patients with a mean age of 56 years, the mean testis dose of radiation measured by TLD was 3.77 Gy, equal to 7.5% of the total prescribed dose. The mean of point doses calculated by the 3-dimensional planning software was 4.11 Gy, equal to 8.1% of the total prescribed dose. A significant relationship was seen between the position of the inferior edge of the fields and the mean testis dose (P= 0.04). Also body mass index (BMI) was inversely related with the testicular dose (P= 0.049). Conclusion: In this study, the mean testis dose of radiation was 3.77 Gy, similar to the dose calculated by the planning software (4.11 Gy). This dose could be significantly harmful for spermatogenesis, though low doses of scattered radiation to the testis in fractionated radiotherapy might be followed with better recovery. Based on above findings, careful attention to testicular dose in radiotherapy of rectal cancer for the males desiring continued fertility seems to be required.http://tumj.tums.ac.ir/browse.php?a_code=A-10-25-5164&slc_lang=en&sid=1azospermia radiotherapy rectal carcinoma testicular radiation dose
spellingShingle Peiman Haddad
Zhaleh Karimimoghaddam
Farshid Farhan
Mahbod Esfahani
Mahdieh Afkhami
Farnaz Amouzegar-Hashemi
Delivered dose to scrotum in rectal cancer radiotherapy by thermoluminescence dosimetry comparing to dose calculated by planning software
Tehran University Medical Journal
azospermia
radiotherapy
rectal carcinoma
testicular radiation dose
title Delivered dose to scrotum in rectal cancer radiotherapy by thermoluminescence dosimetry comparing to dose calculated by planning software
title_full Delivered dose to scrotum in rectal cancer radiotherapy by thermoluminescence dosimetry comparing to dose calculated by planning software
title_fullStr Delivered dose to scrotum in rectal cancer radiotherapy by thermoluminescence dosimetry comparing to dose calculated by planning software
title_full_unstemmed Delivered dose to scrotum in rectal cancer radiotherapy by thermoluminescence dosimetry comparing to dose calculated by planning software
title_short Delivered dose to scrotum in rectal cancer radiotherapy by thermoluminescence dosimetry comparing to dose calculated by planning software
title_sort delivered dose to scrotum in rectal cancer radiotherapy by thermoluminescence dosimetry comparing to dose calculated by planning software
topic azospermia
radiotherapy
rectal carcinoma
testicular radiation dose
url http://tumj.tums.ac.ir/browse.php?a_code=A-10-25-5164&slc_lang=en&sid=1
work_keys_str_mv AT peimanhaddad delivereddosetoscrotuminrectalcancerradiotherapybythermoluminescencedosimetrycomparingtodosecalculatedbyplanningsoftware
AT zhalehkarimimoghaddam delivereddosetoscrotuminrectalcancerradiotherapybythermoluminescencedosimetrycomparingtodosecalculatedbyplanningsoftware
AT farshidfarhan delivereddosetoscrotuminrectalcancerradiotherapybythermoluminescencedosimetrycomparingtodosecalculatedbyplanningsoftware
AT mahbodesfahani delivereddosetoscrotuminrectalcancerradiotherapybythermoluminescencedosimetrycomparingtodosecalculatedbyplanningsoftware
AT mahdiehafkhami delivereddosetoscrotuminrectalcancerradiotherapybythermoluminescencedosimetrycomparingtodosecalculatedbyplanningsoftware
AT farnazamouzegarhashemi delivereddosetoscrotuminrectalcancerradiotherapybythermoluminescencedosimetrycomparingtodosecalculatedbyplanningsoftware